Evgen Pharma PLC (EVG)

London
3.35
-0.10(-2.90%)
  • Volume:
    1,049,617
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    3.35 - 3.35
Unusual trading volume

EVG Overview

Prev. Close
3.45
Day's Range
3.35-3.35
Revenue
-
Open
3.45
52 wk Range
3-9
EPS
-0.01
Volume
1,049,617
Market Cap
9.21M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
243,720
P/E Ratio
-3.47
Beta
1.31
1-Year Change
-39.64%
Shares Outstanding
274,888,117
Next Earnings Date
05 Dec 2022
What is your sentiment on Evgen Pharma PLC?
or
Market is currently closed. Voting is open during market hours.

Evgen Pharma PLC Company Profile

Evgen Pharma PLC Company Profile

Employees
9

Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company’s lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellSellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • just won 2 million bullish
    2